AMG 167

DRUG2 trials

Sponsors

Amgen

Conditions

Osteopenia

Phase 1

A First-in-human Study Evaluating AMG 167 in Healthy Men and Postmenopausal Women

CompletedNCT00902356

AmgenOsteopenia

Start: 2009-05-31End: 2009-11-30Updated: 2010-04-02

An Ascending Multiple Dose Study Evaluating AMG 167 in Healthy Men and Postmenopausal Women With Low Bone Mineral Density

CompletedNCT01101048

AmgenOsteopenia

Start: 2010-06-30End: 2012-02-29Updated: 2018-09-06